Posted on Leave a comment

Driving force: the inside story of how rival companies came together to make ventilators for the COVID-19 pandemic

Every member of the consortium is currently focused on saving lives, but I asked Mathieson and Hoare whether the project would change how McLaren and Ford worked in the future. Will the levels of speed, agility and focus they were forced to adopt be transferred to their own operations?

“Very simply, this is how we need to operate going forward,” Mathieson says. “The auto industry –and it’s true of many other sectors as well – will have to embrace a lot of change, and a lot of that will be focused around technology and culture. This has been a fantastic example of what can be achieved if you get rid of all the normal obstacles, have a clear, laser-sharp focus on the objective, and then people just come together to make it happen.

“Remote working has really come to the fore, and now companies are looking at the future and thinking ‘what space do we need and how do we operate our teams’.”

Workers celebrate the first Penlon ventilators heading to the NHS

Hoare believes HoloLens will continue to have a major impact at Ford.

“When you use technology like HoloLens, all of a sudden the rest of your world starts to change shape,” he says. “We can certainly think of applications for the headset in the automotive world. This technology will set us free, reducing our carbon footprint through reducing the amount our staff have to travel. When we need an answer to a very specific problem, we often end up saying, ‘We need Fred on the plane’, and Fred will fly from Asia to the UK to help solve the problem. Then we realise it actually wasn’t Fred we needed, it was Barry who has the skills we need, so he flies over on a plane. There is tremendous potential for HoloLens there.

“It will be one of the memories I take away from the consortium: how the right tools in the right hands with the right need makes all the difference.”

Posted on Leave a comment

Microsoft and the city of Atlanta lead coalition of partners to close the digital skills gap and build a more inclusive workforce

ATLANTA — July 1, 2020 — On Wednesday, Microsoft Corp. announced “Accelerate,” a new program designed to address economic recovery through both skilling underserved communities and re-skilling the many Americans impacted by COVID-19. Accelerate: Atlanta is the first of many city-focused digital skills and employment partnerships designed to upskill and increase employability.

Accelerate: Atlanta is the first U.S. implementation of Microsoft’s global skills initiative, an ambitious plan to help 25 million people worldwide acquire new digital skills by the end of the year. The announcement supports the needs of Atlantans impacted by the global pandemic and racial inequities in access to education. With support of the mayor’s office and additional public and private partnerships, the initiative aims to accelerate economic recovery from the impact of COVID-19, address the needs of people of underserved communities who require digital skills to stay competitive, and empower them to seize the employment opportunities of the future. Expanding access to digital skills is a critical first step in improving employability to help build local economic recovery, especially for the people hardest hit by job losses.

Accelerate: Atlanta brings together civic, learning and corporate partners to provide skills across the spectrum of digital proficiency to build a more inclusive workforce for all.

  • Empower underserved communities to close the digital divide in the growing workforce.
  • Provide digital skills to promote economic uplift for Atlanta’s populations with the highest susceptibility to automation and COVID-19 impact.
  • Target the market with existing digital fluency to ensure that they can keep up with the advances in AI and machine learning.

Partners in the coalition include:

  • Civic partners: The Office of the Mayor of Atlanta and Metro Atlanta Chamber of Commerce
  • Learning partners: General Assembly, OpenClassrooms and TechBridge
  • Corporate partners: Accenture and others to be announced soon

Microsoft is backing the effort with over $1 million in investments to assist those who need it most, including people with lower income, people with lower educational attainment and racial/ethnic minorities. Atlanta-based nonprofit organizations led by and serving Black/African American communities will be among the 50 such organizations across the United States receiving cash grants to aid in this skills initiative.

“Through Accelerate: Atlanta, Microsoft and its partners will help close the digital divide and ensure there is a place for everyone in our shared future,” said Atlanta Mayor Keisha Lance Bottoms. “The road to economic recovery must begin with pathways to opportunity that are inclusionary and accessible to all. This is more than an initiative — this is an investment in underserved and underrepresented communities that will equip our residents with skills to compete in a modern workforce, while at the same time grow our middle class.”

“Atlanta is the first U.S. city in our ambitious national investment plan to support our country’s economic recovery,” said Kate Johnson, president of Microsoft U.S. “We’re delighted that we can bring the breadth of the Microsoft technology ecosystem in partnership with the mayor to provide communities in Atlanta with the digital skills needed for a more equitable, prosperous future.”

“We’re committed to equipping more communities with the digital skills needed to come back from this crisis even stronger through our work with Microsoft,” said Jake Schwartz, CEO and co-founder at General Assembly. “We’ve been proud to be a part of Atlanta’s thriving tech, startup and innovation ecosystem for years, and are thrilled to continue our investment in the community while advancing this important national partnership with the launch of Accelerate: Atlanta.”

“Microsoft shares our commitment to serving underrepresented communities with equity, access and opportunity. We are thrilled to align our mission of ‘breaking the cycle of generational poverty through the innovative use of technology’ with Microsoft and the Atlanta community to close the digital divide, creating real opportunities for those who need it most,” said Nicole Armstrong, CEO of TechBridge.

“I applaud Microsoft and the many partners working to make Accelerate: Atlanta a success. Our region is uniquely situated to benefit from this initiative through our dense innovation community coupled with the presence of noted higher education institutions training our brightest minds,” said Metro Atlanta Chamber President and CEO Katie Kirkpatrick. “I am excited to see the progress as Accelerate: Atlanta closes the digital divide and equips the next generation with the in-demand skills needed to succeed.”

“Accenture is committed to advancing equality for all people all the time, and to doing more to drive sustained change in our communities,” said Jimmy Etheredge, Accenture’s CEO for North America. “We are pleased to join Microsoft and our coalition partners in Atlanta to equip more of our citizens with the digital skills they need to be prepared for the jobs of the future — and we look forward to extending the impact of this initiative across the United States.”

More information can be found at https://aka.ms/AccelerateAtlanta.

Microsoft (Nasdaq “MSFT” @microsoft) enables digital transformation for the era of an intelligent cloud and an intelligent edge. Its mission is to empower every person and every organization on the planet to achieve more.

For more information, press only:

Microsoft Media Relations, WE Communications, (425) 638-7777, [email protected]

Note to editors: For more information, news and perspectives from Microsoft, please visit the Microsoft News Center at http://news.microsoft.com. Web links, telephone numbers and titles were correct at time of publication, but may have changed. For additional assistance, journalists and analysts may contact Microsoft’s Rapid Response Team or other appropriate contacts listed at https://news.microsoft.com/microsoft-public-relations-contacts.

Posted on Leave a comment

Microsoft to help 25 million people worldwide acquire new digital skills needed for the COVID-19 economy

REDMOND, Wash. — June 30, 2020 — Microsoft Corp. on Tuesday announced a new global skills initiative aimed at bringing more digital skills to 25 million people worldwide by the end of the year.

The announcement comes in response to the global economic crisis caused by the COVID-19 pandemic. Expanded access to digital skills is an important step in accelerating economic recovery, especially for the people hardest hit by job losses.

This initiative, detailed on the Official Microsoft Blog, includes immediate steps to help those looking to reskill and pursue an in-demand job and brings together every part of the company, combining existing and new resources from LinkedIn, GitHub and Microsoft. This includes:

  • The use of data to identify in-demand jobs and the skills needed to fill them.
  • Free access to learning paths and content to help people develop the skills these positions require.
  • Low-cost certifications and free job-seeking tools to help people who develop these skills pursue new jobs.

This is a comprehensive technology initiative that will build on data and digital technology. It starts with data on jobs and skills from the LinkedIn Economic Graph. It provides free access to content in LinkedIn Learning, Microsoft Learn and the GitHub Learning Lab, and couples those with Microsoft Certifications and LinkedIn job seeking tools. These resources can all be accessed at a central location, opportunity.linkedin.com, and will be broadly available online in four languages: English, French, German and Spanish.

In addition, Microsoft is backing the effort with $20 million in cash grants to help nonprofit organizations worldwide assist the people who need it most. One-quarter of this total, or $5 million, will be provided in cash grants to community-based nonprofit organizations that are led by and serve communities of color in the United States. The company is also pledging to make stronger data and analytics — including data from the LinkedIn Economic Graph — available to governments around the world so they can better assess local economic needs.

Microsoft will use its voice to advocate for public policy innovations that will advance skilling opportunities needed in the changed economy.

Microsoft also announced it is creating a new learning app in Microsoft Teams designed to help employers skill and upskill new and current employees as people return to work and as the economy adds jobs.

“COVID-19 has created both a public health and an economic crisis, and as the world recovers, we need to ensure no one is left behind,” said Microsoft CEO Satya Nadella. “Today, we’re bringing together resources from Microsoft inclusive of LinkedIn and GitHub to reimagine how people learn and apply new skills — and help 25 million people facing unemployment due to COVID-19 prepare for the jobs of the future.”

“The biggest brunt of the current downturn is being borne by those who can afford it the least,” said Microsoft President Brad Smith. “Unemployment rates are spiking for people of color and women, as well as younger workers, people with disabilities and individuals with less formal education. Our goal is to combine the best in technology with stronger partnerships with governments and nonprofits to help people develop the skills needed to secure a new job.”

“Creating opportunity for every member of the global workforce drives everything we do at LinkedIn,” said LinkedIn CEO Ryan Roslansky. “As a part of the Microsoft ecosystem, we have the unique ability to help job seekers around the world — especially those who have been disproportionately disadvantaged during the COVID-19 crisis — gain the skills and find the jobs they deserve. We’re proud to be bringing the right data about what the jobs and skills of the future will be to create the right learning paths to help 25 million job seekers find their next opportunities. We’re making it all available at opportunity.linkedin.com.”

More information can be found at the Microsoft microsite news.microsoft.com/skills.

Microsoft (Nasdaq “MSFT” @microsoft) enables digital transformation for the era of an intelligent cloud and an intelligent edge. Its mission is to empower every person and every organization on the planet to achieve more.

For more information, press only:

Microsoft Media Relations, WE Communications, (425) 638-7777, [email protected]

Note to editors: For more information, news and perspectives from Microsoft, please visit the Microsoft News Center at http://news.microsoft.com. Web links, telephone numbers and titles were correct at time of publication, but may have changed. For additional assistance, journalists and analysts may contact Microsoft’s Rapid Response Team or other appropriate contacts listed at https://news.microsoft.com/microsoft-public-relations-contacts.

Posted on Leave a comment

Microsoft Store announces new approach to retail

Microsoft to continue to support customers online, with retail team members working remotely and at Microsoft corporate locations

REDMOND, Wash. — June 26, 2020 — Microsoft Corp. (NASDAQ: MSFT) (“Microsoft”) today announced a strategic change in its retail operations, including closing Microsoft Store physical locations. The company’s retail team members will continue to serve customers from Microsoft corporate facilities and remotely providing sales, training, and support. Microsoft will continue to invest in its digital storefronts on Microsoft.com, and stores in Xbox and Windows, reaching more than 1.2 billion people every month in 190 markets. The company will also reimagine spaces that serve all customers, including operating Microsoft Experience Centers in London, NYC, Sydney, and Redmond campus locations. The closing of Microsoft Store physical locations will result in a pre-tax charge of approximately $450M, or $0.05 per share, to be recorded in the current quarter ending June 30, 2020. The charge includes primarily asset write-offs and impairments.

“Our sales have grown online as our product portfolio has evolved to largely digital offerings, and our talented team has proven success serving customers beyond any physical location,” said Microsoft Corporate Vice President David Porter. “We are grateful to our Microsoft Store customers and we look forward to continuing to serve them online and with our retail sales team at Microsoft corporate locations.”

Since the Microsoft Store locations closed in late March due to the COVID-19 pandemic, the retail  team has helped small businesses and education customers digitally transform; virtually trained hundreds of thousands of enterprise and education customers on remote work and learning software; and helped customers with support calls. The team supported communities by hosting more than 14,000 online workshops and summer camps and more than 3,000 virtual graduations.

“We deliberately built teams with unique backgrounds and skills that could serve customers from anywhere. The evolution of our workforce ensured we could continue to serve customers of all sizes when they needed us most, working remotely these last months,” said Porter. “Speaking over 120 languages, their diversity reflects the many communities we serve. Our commitment to growing and developing careers from this talent pool is stronger than ever.”

The retail team members will serve consumers, small-business, education, and enterprise customers, while building a pipeline of talent with transferable skills.

“The Microsoft Store team has long been celebrated at Microsoft and embodies our culture,” said Microsoft Chief People Officer Kathleen Hogan. “The team has a proven track record of attracting, motivating, and developing diverse talent. This infusion of talent is invaluable for Microsoft and creates opportunities for thousands of people.”

With significant growth through its digital storefronts, including Microsoft.com, and stores on Xbox and Windows, the company will continue to invest in digital innovation across software and hardware. New services include 1:1 video chat support, online tutorial videos, and virtual workshops with more digital solutions to come.

“It is a new day for how Microsoft Store team members will serve all customers,” said Porter. “We are energized about the opportunity to innovate in how we engage with all customers, maximize our talent for greatest impact, and most importantly help our valued customers achieve more.”

About Microsoft

Microsoft (Nasdaq “MSFT” @microsoft) enables digital transformation for the era of an intelligent cloud and an intelligent edge. Its mission is to empower every person and every organization on the planet to achieve more.

Forward-Looking Statements

Statements in this release that are “forward-looking statements” are based on current expectations and assumptions that are subject to risks and uncertainties. Actual results could differ materially because of factors such as:

  • intense competition in all of our markets that may lead to lower revenue or operating margins;
  • increasing focus on cloud-based services presenting execution and competitive risks;
  • significant investments in products and services that may not achieve expected returns;
  • acquisitions, joint ventures, and strategic alliances that may have an adverse effect on our business;
  • impairment of goodwill or amortizable intangible assets causing a significant charge to earnings;
  • cyberattacks and security vulnerabilities that could lead to reduced revenue, increased costs, liability claims, or harm to our reputation or competitive position;
  • disclosure and misuse of personal data that could cause liability and harm to our reputation;
  • the possibility that we may not be able to protect information stored in our products and services from use by others;
  • abuse of our advertising or social platforms that may harm our reputation or user engagement;
  • the development of the internet of things presenting security, privacy, and execution risks;
  • issues about the use of artificial intelligence in our offerings that may result in competitive harm, legal liability, or reputational harm;
  • excessive outages, data losses, and disruptions of our online services if we fail to maintain an adequate operations infrastructure;
  • quality or supply problems;
  • the possibility that we may fail to protect our source code;
  • legal changes, our evolving business model, piracy, and other factors may decrease the value of our intellectual property;
  • claims that Microsoft has infringed the intellectual property rights of others;
  • claims against us that may result in adverse outcomes in legal disputes;
  • government litigation and regulatory activity relating to competition rules that may limit how we design and market our products;
  • potential liability under trade protection, anti-corruption, and other laws resulting from our global operations;
  • laws and regulations relating to the handling of personal data that may impede the adoption of our services or result in increased costs, legal claims, fines, or reputational damage;
  • additional tax liabilities;
  • damage to our reputation or our brands that may harm our business and operating results;
  • exposure to increased economic and operational uncertainties from operating a global business, including the effects of foreign currency exchange;
  • uncertainties relating to our business with government customers;
  • adverse economic or market conditions that may harm our business;
  • catastrophic events or geo-political conditions, such as the COVID-19 pandemic, that may disrupt our business; and
  • the dependence of our business on our ability to attract and retain talented employees.

For more information about risks and uncertainties associated with Microsoft’s business, please refer to the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Risk Factors” sections of Microsoft’s SEC filings, including, but not limited to, its annual report on Form 10-K and quarterly reports on Form 10-Q, copies of which may be obtained by contacting Microsoft’s Investor Relations department at (800) 285-7772 or at Microsoft’s Investor Relations website at http://www.microsoft.com/en-us/investor.

The company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company’s expectations.

For more information, press only:

Microsoft Media Relations, WE Communications for Microsoft, (425) 638-7777, [email protected]

For more information, financial analysts and investors only:

Michael Spencer, General Manager, Investor Relations, (425) 706-4400

Posted on Leave a comment

Using AI to help governments think through COVID-19’s impact and strategies for recovery

In any time of uncertainty, it is critical we leverage data-driven approaches when solving problems. About a decade ago, we wrote on this blog how we used a data- and model-driven approach to guide us to the cloud as the future of enterprise computing. Today, we’re applying the same foundational approach while benefiting from the power of our cloud and AI capabilities to unpack today’s source of great uncertainty: COVID-19. In the white paper we are releasing today, we outline a policy framework to help governments think through the impact of COVID-19 and recovery strategies. We have also included an economic model that quantifies economic impact.

Economic impact framework

As the white paper highlights, our economic impact model is built on a large dataset of economic signals and takes insights from economics and epidemiologists to define scenarios and estimate GDP impact. We ingest real-time data as well as traditional economic data, use our Azure AI capabilities to drive insights, our Azure cloud to run calculations, and we update the latest numbers weekly on our Power BI dashboard. We continue to evolve and improve the model as we ingest new signals and learn more from others through our discussions with policymakers and NGOs. But policymakers don’t merely predict GDP; they help shape it. As we engaged with them, we saw the need for a framework and data that helped them navigate this.

covid strategy graphic

Social contact budget

“Social contact” used to be something we didn’t have to think about. It was a byproduct of going to the store or the gym, often viewed as a positive byproduct. Since the start of COVID-19, it comes at a high price. Today, it can perhaps be compared to carbon emissions: an unwelcome byproduct of economic activity. One can lead to pollution; the other to infection. In economic terms, social contact has become a scarce resource. It has become the linchpin between managing infections and protecting the economy – it is what is driving up infection rates but is also needed for economic activity. By treating it as an economically scarce resource, it raises three critical questions that we began to address in the paper in a data-driven way:

  1. How much room do we have to open the economy (“social contact budget”)?
  2. How do we best spend the budget (“return on social contact”)?
  3. How do we grow our social contact budget over time (“reducing cost of social contact”)?

On the first question, the lower the transmission rate “R” (R being the average number of secondary cases per infectious case), the greater the social contact budget and thus the more room there is to open up parts of the economy while avoiding a second wave of infections, which is very costly from a health and an economic perspective. Second, as is true with any budget, we must spend it wisely. Depending on what a policymaker optimizes for (e.g. GDP, employment, avoiding bankruptcy), we created data-driven views on how to optimize return on social contact. Industries that can work from home should work from home, as the ones who cannot need the social contact budget more. For the ones who really depend on social contact, we should use data to inform decisions. For example, the figures below compare various industries on their propensity to drive social contact vs. GDP.

cost of social contact graph

Finally, over time, the budget can be expanded through changes in behavior as people adjust to the “cost of social contact” and through measures such as massive testing and contact tracing. These measures essentially weaken the relationship between social contact and R. They ensure that social contact happens between healthy people that do not carry the virus so, over time, we can essentially make social contact free again, as it should be.

This crisis is unprecedented, and no single person or organization has all the answers. New perspectives often appear by recognizing and connecting patterns across silos. We’ve been working with epidemiologists whose work focuses on the potential loss of lives. Economic models and scenarios highlight the loss of livelihoods. As we started discussing this with NGOs and global policymakers, we became aware of the synergies between these workstreams, and we sought an integrated perspective.

In the paper, we detail this framework and share data we have been collaborating on with policymakers. It is by no means perfect. We are already collaborating with a number of organizations on improving this work and getting additional data. Our hope is that, by publishing this work, we can invite others to contribute and leverage it so that we can bring more perspectives to bear on one of the great challenges of our lifetime.

Tags: , , , ,

Posted on Leave a comment

Growing Azure’s capacity to help people during the COVID-19 pandemic

Within 12 days, the state was able to launch the Washington Healthcare Emergency and Logistics Tracking Hub (WA HEALTH) built on Microsoft Power Platform, which runs on Microsoft Azure.

“This really helped us understand how do we get patients to the right care at the right place in the right amount of time and also to understand the needs for personal protective equipment across the state — who had what and where were the gaps,” Henry said.

Cloud providers like Microsoft Azure are by their nature designed to expand and scale quickly and meet elastic demand. With the more than 60 datacenter regions around the globe — including three new regions announced this past May in Italy, New Zealand and Poland — Microsoft can shift traffic if a natural disaster or power outage affects capacity in one part of the world. Computing hardware to protect against demand spikes is stockpiled in warehouses around the globe, ready to be deployed to where it’s needed most.

By March the epicenter of that demand was in Europe, as countries such as Italy and Spain imposed nationwide lockdowns to slow the spread of the coronavirus. Around the same time, manufacturing issues in China and Southeast Asia due to the global health pandemic created a temporary disruption in the supply chain for certain datacenter hardware as dramatic spikes in usage began challenging computing capacity in some regions. In a Microsoft quarterly earnings call on April 29, the company said those hardware supply chain issues largely began resolving themselves late in the quarter that ended in March.

“The scope and the scale of the response to COVID-19 was completely unprecedented, in terms of how much of the world went digital inside a month,” said Mark Simms, a senior Azure engineer who helped manage the COVID-19 response across Azure. “So the work that we had to do to get through the initial surge in demand and free up capacity for our customers to run critical health and safety workloads was also unprecedented.”

“We made some pretty profound changes in order to do the right thing, and we did them under a very short time frame,” Simms said.

Datacenter employees began working in round-the-clock shifts to install new servers while staying at least six feet apart. Microsoft product teams worked to find any further efficiencies to free up Azure resources for other customers. The company doubled capacity on one of its own undersea cables carrying data across the Atlantic and negotiated with owners of another to open up additional capacity. Network engineers installed new hardware and tripled the deployed capacity on the America Europe Connect cable in just two weeks.

Microsoft’s plan emphasized continuity of service for all its customers, but especially for those on the front lines of the COVID-19 response: health care providers, police and emergency responders, financial institutions, manufacturers of critical supplies, grocery stores and health agencies providing critical information to the public about how quickly the virus was spreading.

The Azure Global and Customer Experience engineering teams mobilized and monitored Azure services around the clock to ensure critical customers could continue to operate smoothly and meet new challenges posed by COVID-19. Employees from across the company volunteered to switch gears to help deploy urgent projects like WA HEALTH.

Microsoft’s Regional Government Emergency Response and Monitoring Solution, on which WA HEALTH was built, uses Microsoft Power Apps Portal and Microsoft Power BI, which run on Azure, to allow healthcare workers to quickly update counts of COVID-19 cases and critical resources at the end of a shift or whenever is convenient through a web portal or by mobile phone.

As the pandemic was unfolding and cases were surging, it allowed state and local health officials to use near-real-time dashboards — based on data from more than 100 acute care hospitals around the state — to coordinate responses. It continues to allow the state to monitor trends, as well as inform decisions such as how quickly counties can move toward safely reopening their economies, Henry said.

“This was a real-time moving event, and people needed to make decisions hour by hour and minute by minute,” said Gary Bird, a principal program manager for Microsoft Power Platform who worked to deploy WA HEALTH. “You really saw the whole company lean in across all fronts to make solutions happen.”

A screenshot of the Washington Healthcare Emergency and Logistics Tracking Hub (WA HEALTH)
The Washington Healthcare Emergency and Logistics Tracking Hub (WA HEALTH), which runs on Microsoft Azure, allows public health officials and hospitals across the state to track and share key information related to the COVID-19 pandemic.

Balancing supply and demand

Once the pandemic hit, Microsoft’s plans to deal with unexpected spikes in usage and expand Azure’s computing resources kicked in. The company began adding new servers to the hardest hit regions and installing new hardware racks 24 hours a day. To protect the health of critical datacenter employees, Microsoft also quickly established social distancing requirements, provided protective equipment and implemented strict disinfectant policies.

Microsoft prioritized capacity for existing customers while also reserving capacity for first responders who needed to quickly scale life and safety services. It also expanded cloud support for non-profits working to protect people’s health during the pandemic.

Microsoft’s Azure and product teams worked around the clock to ensure that services like Teams, Office and Xbox could meet rapidly exploding demand from customers. Next, they looked for efficiencies across all of Microsoft services running on Azure to free up more capacity for external customers.

Microsoft Teams was the first and most obvious service to experience massive growth. But other Azure services that enable remote work, such as Windows Virtual Desktop, which saw its usage triple in one month, and Azure Active Directory’s Application Proxy had to scale those services dramatically as financial institutions, schools, call centers and other companies moved thousands of employees onto those platforms practically overnight.

Not only were new customers signing up, but suddenly existing users were relying on the tools to power every single meeting or interaction in their workday, said Mark Longton, a principal group program manager for Microsoft Teams.

“Teams went from a service that was cool and convenient and something that people realized was the future of communication to very quickly becoming a mission critical, can’t-live-without-it sort of thing,” Longton said. “Really what this did was accelerate us into the future.”

Microsoft Teams began using early data from China and Italy to plan for expected growth as the pandemic spread. As more countries went into lockdown, dozens of Redmond-based Microsoft employees gathered remotely each Sunday night to watch telemetry, look for bottlenecks and troubleshoot as unprecedented numbers of remote European workers began logging in first thing Monday morning.

“Normally, you find and fix issues organically as you grow. When you take software and put it under explosive growth – with services getting used an order of magnitude more in one day — you tend to find all of those in a really short period of time,” said John Sheehan, Microsoft distinguished engineer for Azure quality.

Once critical services were successfully scaled and stabilized, the company shifted to looking for efficiencies. Microsoft opened up performance data for all services running on Azure to engineers across the company, asking them to submit ideas that would allow Microsoft to provide more computing capacity to the wider pool of Azure customers.

In Teams, small tweaks that few customers would notice — lengthening the time it takes for the three dots to appear when someone else is typing in a Teams chat or disabling the feature that suggests a contact every time you type a new letter in the “to” field — made the system run much more leanly. Engineers rewrote the code to make video stream processing 10 times more efficient in a marathon push over a weekend.

Posted on Leave a comment

Adaptive Biotechnologies and Microsoft launch groundbreaking ImmuneCODE database to share populationwide immune response to the COVID-19 virus

Decoding the immune response to the virus from thousands of patient samples may contribute to the development of novel diagnostics, vaccines and therapeutics

Data will be updated regularly and made freely available to researchers and public health officials around the world

SEATTLE and REDMOND, Wash. — June 11, 2020 Adaptive Biotechnologies Corp. (Nasdaq: ADPT) on Thursday launched ImmuneCODE with Microsoft Corp. (Nasdaq: MSFT) to begin sharing one of the largest, most detailed views of the immune response to COVID-19 in real time based on de-identified data generated from thousands of COVID-19 blood samples from patients around the globe. The open database contains detailed information on the extraordinarily diverse set of T cells shown to specifically recognize unique features of the COVID-19 virus, called antigens, with unprecedented speed and scale. T cells contain a treasure trove of information that could provide one consistent and trackable measure of the immune response. This could help diagnose and manage COVID-19 from exposure through clearance of the virus, and potentially offer an accurate assessment of immunity. Data from ImmuneCODE will accelerate ongoing global efforts to develop better diagnostics, vaccines and therapeutics and answer important questions about the virus to support initiatives to safely reopen society.

“In just a few months, Adaptive and Microsoft intend to generate data for ImmuneCODE sufficient to accurately map how the adaptive immune system responds to SARS-CoV-2 from initial exposure through clearance by using our combined immune medicine platform and machine learning, potentially providing an accurate assessment of immunity,” said Harlan Robins, chief scientific officer and co-founder of Adaptive Biotechnologies. “The scale and precision with which we are now able to decode the T cell response to the virus may fundamentally change our ability to recover from this pandemic and the way in which all viruses are studied in the future.”

Thousands of de-identified geographically and ethnically diverse patient blood samples from institutions around the world* are being collected and analyzed alongside samples from ImmuneRACE (Immune Response Action to COVID-19 Events), the companies’ prospective study enrolling 1,000 participants across the U.S. to decode how immune systems detect and respond to the virus. Using Microsoft Azure’s hyperscale cloud and machine learning capabilities, the T cell response signature will be continuously refined by extending the number of matches of COVID-19-related T cells to antigens and directly associating this T cell signature with disease and outcomes.

“Adaptive Biotechnologies’ sequencing of T-cells sets up an extremely large but manageable machine learning problem, and thus makes it possible, for the first time, to catalog and share how our adaptive immune system responds to viruses, including the novel virus that causes COVID-19,” said Peter Lee, corporate vice president, Microsoft Research and Incubation. “Making these data freely available to the global research community through the ImmuneCODE database will deepen our collective understanding of the human immune response and thereby help researchers accelerate the development of news drugs and vaccines in the fight against this global health crisis.”

The role of the T cell

Although most efforts to look at the immune response are focused on the B cell or the virus itself, this approach is different because it focuses on the T cell. T cells are the adaptive immune system’s first responders to detect any virus. They quickly multiply and circulate in the blood to attack the virus, often before symptoms appear. Among many other jobs, T cells also recruit B cells to produce antibodies after about a week or two to potentially provide immunity against future infection.

To date, testing for COVID-19 has either been in the form of a viral test to detect the presence of the virus or a serology test to detect the presence of antibodies to signal prior infection. An in-depth understanding of the T cell response to the COVID-19 virus has a variety of different applications. That in-depth understanding may improve accuracy in the existing testing paradigm or potentially provide an assessment of immunity. Additionally, it is possible that identifying and tracking T cell response may provide insight as to the severity of a patient’s illness, the length of any post-infection immunity period, and the potential efficacy of vaccines in development.

As Adaptive generates these data, subsequent updates to ImmuneCODE will provide an increasingly clearer picture of the immune response to the COVID-19 virus. This includes analyzing the immune responses from thousands of infected individuals, linking T cell responses to viral antigens and patient outcomes, and tracking the immune response. In addition to making these data freely available, Adaptive is conducting its own research to develop a new kind of diagnostic looking specifically at the T cell response to the COVID-19 virus.

About ImmuneCODE

ImmuneCODE is an open database that provides a detailed population-level view into the adaptive immune response to the COVID-19 virus. Adaptive Biotechnologies and Microsoft are making these data freely available to any researcher, public health official or organization around the world to accelerate solutions to the global pandemic. The database contains detailed information on the virus-specific T cells as well as the virus-related antigens they recognize. The T cell responses to these antigens will be tracked across the population to create an immune response signature using thousands of de-identified samples combined from organizations around the globe and ImmuneRACE, the virtual clinical study launched in May to help in the race to find a solution to COVID-19.

De-identified blood samples from ImmuneRACE, including patients who were actively infected, recovered or were recently exposed to the virus, are being collected by LabCorp, through its Covance drug development business, using a mobile phlebotomy service. Immune cell receptors from these samples are being sequenced using Illumina platform technology and mapped to virus-specific antigens that are confirmed by Adaptive’s proprietary immune medicine platform to induce an immune response. These study data are being pooled with data from thousands of additional unique de-identified patient samples from many institutions around the world. Using Microsoft Azure’s hyperscale cloud and machine learning capabilities, the accuracy of the immune response will be continuously improved and updated online in real time as more samples are sequenced.

* Providence, a large health system with 51 hospitals, including the one near Seattle that treated the first U.S. COVID-19 patient, is an initial clinical collaborator. Other participating institutions include Institute for Systems Biology (ISB), BloodWorks Northwest, Hospital 12 de Octubre, i+12/CNIO (Madrid, Spain), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS (Meldola, FC – Italy) / AUSL-Romagna and Department of Experimental, Diagnostic and Specialty Medicine (DIMES), and Università di Bologna (Italy). This list is growing as we continue to work with other investigators globally to collect and sequence valuable patient cohorts. Institutions or collaborators interested in contributing blood samples can direct inquiries to [email protected].

About the Adaptive and Microsoft partnership

Adaptive and Microsoft partnered in 2018 to create a TCR-Antigen Map, an approach to translating the genetics of the massive adaptive immune system to understand how it works. Together we are using immunosequencing at scale and machine learning to map T-cell receptor (TCR) sequences to diseases and disease-associated antigens. Using these data, we aim to develop a blood test for the early and accurate detection of many diseases, translating the natural diagnostic capability of the immune system into the clinic. In 2019, we confirmed clinical signals in two diseases, and established our first proof of concept in Lyme disease. We expect to submit our first clinical application to the FDA in 2020.

About Adaptive Biotechnologies

Adaptive Biotechnologies is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. We believe the adaptive immune system is nature’s most finely tuned diagnostic and therapeutic for most diseases, but the inability to decode it has prevented the medical community from fully leveraging its capabilities. Our proprietary immune medicine platform reveals and translates the massive genetics of the adaptive immune system with scale, precision and speed to develop products in life sciences research, clinical diagnostics, and drug discovery. We have two commercial products, and a robust clinical pipeline to diagnose, monitor and enable the treatment of diseases such as cancer, autoimmune conditions and infectious diseases. Our goal is to develop and commercialize immune-driven clinical products tailored to each individual patient. For more information, please visit adaptivebiotech.com and follow us on www.twitter.com/adaptivebiotech.

This press release contains forward-looking statements that are based on beliefs and assumptions and on information currently available to Adaptive. All statements contained in the press release other than statements of historical fact are forward-looking statements, including statements regarding the ability to map adaptive immune responses to COVID-19, the ability to successfully collect a sufficient number and quality of samples through ImmuneRACE, the ability to efficiently and effectively process data with ImmuneCODE, to leverage any findings or data to advance solutions to diagnose, treat and prevent COVID-19, the ability to develop, commercialize and achieve market acceptance of the Adaptive’s TCR-Antigen Map and other current and planned products and services, research and development efforts. These statements involve risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements, which are described under “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere in the documents Adaptive files with the Securities and Exchange Commission from time to time.

About Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit www.illumina.com and follow @illumina.

About LabCorp

LabCorp (NYSE: LH), an S&P 500 company, is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. With a mission to improve health and improve lives, LabCorp delivers world-class diagnostics solutions, brings innovative medicines to patients faster, and uses technology to improve the delivery of care. LabCorp reported revenue of more than $11.5 billion in 2019. To learn more about LabCorp, visit www.LabCorp.com, and to learn more about LabCorp’s Covance drug development business, visit www.Covance.com.

About Providence

Providence is a national, not-for-profit Catholic health system comprising a diverse family of organizations and driven by a belief that health is a human right. With 51 hospitals, 1,085 physician clinics, senior services, supportive housing and many other health and educational services, the health system and its partners employ more than 120,000 caregivers serving communities across seven states – Alaska, California, Montana, New Mexico, Oregon, Texas, and Washington, with system offices in Renton, Wash., and Irvine, Calif.

About Microsoft

Microsoft (Nasdaq “MSFT” @microsoft) enables digital transformation for the era of an intelligent cloud and an intelligent edge. Its mission is to empower every person and every organization on the planet to achieve more.

For more information, press only:

Microsoft Media Relations, WE Communications for Microsoft, (425) 638-7777, [email protected]

Beth Keshishian, Adaptive Media, (917) 912-7195, [email protected]

Karina Calzadilla, Adaptive Investor Relations, Carrie Mendivil, Gilmartin Group, [email protected]

Note to editors: For more information, news and perspectives from Microsoft, please visit the Microsoft News Center at http://news.microsoft.com. Web links, telephone numbers and titles were correct at time of publication but may have changed. For additional assistance, journalists and analysts may contact Microsoft’s Rapid Response Team or other appropriate contacts listed at https://news.microsoft.com/microsoft-public-relations-contacts.

Posted on Leave a comment

Empowering Asia’s health care sector in the battle against COVID-19

The response to the COVID-19 pandemic is stretching health care systems across the Asia Pacific region and around the world. The infrastructure and supply chains of health care providers are being challenged, and our health care front-liners work tirelessly to provide treatment and support in a time of unprecedented demand for patient care. And if there is one question on the minds of those of the pandemic’s front-line it is most likely: “Can we do more with less?”

It is crucial to speed up routine tasks and services, especially during this time when a growing number of patients and limited resources can quickly overwhelm staff. We have seen how collaboration with customers and partners has taken on a speed and agility that we’ve not encountered before and how new cloud-based solutions, often leveraging artificial intelligence (AI) and machine learning, can do much to augment the work of doctors, nurses and first responders.

Dr. Keren Priyadarshini, regional business lead, Worldwide Health, Microsoft Asia
Dr. Keren Priyadarshini.

It can start with better managing resources and protecting the health of personnel and patients from the very moment someone enters a hospital.

Taipei’s Yonghe Cardinal Tien Hospital deployed digital first-line protection measures and resource management in the early stages of the COVID-19 outbreak. It installed a “2-in-1” detection device at its main entrance that collects and analyzes data with AI and machine learning to scan individuals as they enter the hospital’s lobby. It sends out an alert if there are potential health concerns – such as a raised temperature. Scanning from a distance and autonomously minimizes risk for everyone. It also has delivered much-needed efficiencies by significantly streamlining the number of staff who are needed to monitor arrivals. That means more time and personnel can be allocated to patient care.

Similarly, Austin Health in Melbourne has introduced COVID-Care systems to improve their capacity to cope with anticipated demand. Patients no longer have to come to the hospital but can use a self-assessment tool instead. If advised to be tested, they are also advised of the nearest testing clinic or, if directed to Austin Health, can book an appointment. Another of the system’s tools monitors the symptoms of recuperating patients. Using AI and algorithms, COVID-Care automatically alerts doctors to follow up with patients via telehealth consultations and determine if the patient needs to go to the hospital or can stay home.

AI and machine learning can greatly assist front-liners and alleviate the stress on our health care systems. Since the beginning of March, health organizations have created 1,600 COVID-19 self-assessment bots with the Microsoft Healthcare bot service that help respond to inquiries and free up health care workers. This has served over 31 million individuals across 23 countries to date. More than ever, it is crucial that patient needs are met despite limited resources, to ensure the well-being of our communities and technology can support that.

Ensuring accessibility to health care in safe conditions through remote care

There are more challenges when a patient is fighting COVID-19 along with existing medical issues. Let’s take for example a COVID-19 patient who also has a broken limb. Could an orthopedic doctor attend to the patient without entering the isolation ward themselves?

The team at Austin Health has addressed this with their deployment of Microsoft Teams and Teams Navigator to help their 8,500 staff collaborate and assist doctors in conducting virtual ward rounds. They can check in on their patients in the isolation wards, while maintaining a safe distance.

In India, Fortis Healthcare has introduced tele-consultations, which have proved helpful for those like expectant mothers and individuals with mental health conditions who need continuous treatment and high frequency care.

We see how health care providers like HealthCare Global (HCG), India’s largest provider of cancer care, addressed this challenge by adopting Teams Virtual Consult. Doctors now schedule and conduct virtual consultations with patients who can continue receiving the necessary care from the safety of their homes.

Similarly, in China, Sichuan’s Huili County People’s Hospital and Chengdu’s Third People’s Hospital deployed a remote consultation platform, connecting patients in need from a remote part of the country with the quality medical care provided from a distant facility. Doctors use Surface, Azure and AI to carry out remote online consultations. They can also discuss cases and diagnoses with fellow physicians remotely.

Reimagining access to healthcare

Bain and Company’s 2020 Asia-Pacific Front Line of Healthcare survey revealed that the adoption of digital health services due to COVID-19 is not just unprecedented, but also one that will endure. Nearly 50% of patients said that they expect to use digital health tools in the next five years, and 91% of consumers said they would if the costs were covered by an insurance provider or employer.

Dr. David Rhew, global medical chief officer at Microsoft, reinforces this perspective, saying, “This pandemic has given us a great understanding that we need digital tools in health care. Tools that enable everything from telehealth to remote patient monitoring, care team collaboration and care at home. Virtualizing and streamlining other aspects of care from ventilator management to supply chain management have now become vital elements of health care in the COVID-19 era.”

Access to medical supplies, especially as countries remain under lockdown, is another critical element for the safety and well-being of communities. In response, Zuellig Pharma, one of the largest health care services groups in Asia, ensures that vital supplies get to those who need them. They launched a 24/7 interactive engagement platform to assist their customers – hospitals, clinics and pharmacies – with placing orders for prescription drugs, medical devices or consumer health products any time, anywhere to make sure that every medical facility and every patient have access to the medicines they need.

During the pandemic, limited access and possible shortages to pharmaceutical supplies have raised concerns around counterfeit drugs entering the market. In response, Zuellig Pharma has also fast-tracked the development of eZTracker, which allows consumers to verify the authenticity of a medicine by scanning a code on the packaging.

Gearing up for the battle ahead

In the short span of time since the emergence of COVID-19, we have already seen significant changes in the way that health care is delivered. Undoubtedly, the pandemic will have a profound impact on the whole industry for years to come.

I cannot agree more with Dr. Rhew, who emphasized that, “a safer return to the workplace will require a lot of changes in how businesses will be run. Every organization must adjust, and Microsoft has the ability to support them.”

As efforts to battle the pandemic continue, we are hopeful that technology will continue to play a meaningful role in equipping health care experts with the tools they need for meaningful patient care and contributing toward research for a cure.

As part of our efforts, Microsoft has mobilized an AI for Health initiative with $20 million dedicated to help on the front lines of research, where our data scientists can best contribute: data and insights; treatment and diagnostics; allocation of resources; dissemination of accurate information; and scientific research.

We’ll also be offering Microsoft Cloud for Healthcare, our first industry-specific cloud offering,  in October. This will help bring together capabilities for customers and partners to enrich patient engagement, connect caregiving teams and improve operational efficiencies. Ultimately, to address the most pressing challenges the industry is facing today.

We’ll also continue to work with our partners, including ATGENOMIX, a startup in Taiwan that is providing virus genome sequencing technology, which runs on Azure HPC, to speed up research and health care analysis, and support vaccine development

Ultimately, the collaboration across our broad ecosystem and beyond is crucial to effectively address the challenges of this global crisis and support our customers in building their resilience and agility so they can continue to provide so much needed care for the communities.

We are committed to working together to empower health care organizations in the fight against the adverse effects of the pandemic and in the long run, support their pivot toward better experiences, better insights and better care.

(Top photo by kumikomini/Getty Images)

Posted on Leave a comment

Racing against time, medical researchers, life science companies and COVID-19 survivors launch national campaign to drive blood plasma donation

“The Fight Is In Us” campaign seeks to mobilize COVID-19 survivors to accelerate the development of potentially lifesaving therapies

REDMOND, Wash., USA, and NEW YORK — May 26, 2020 — A coalition of world-leading medical and research institutions, blood centers, life science companies, technology companies, philanthropic organizations, and COVID-19 survivor groups has come together to support the rapid development of potential new therapies for patients with COVID-19. Working together under the “The Fight Is In Us” campaign, the coalition is seeking to mobilize tens of thousands of people in the United States who have recovered from COVID-19 to donate their blood plasma, which contains vital antibodies that have fought off the disease and could now help others do the same.

The campaign is working against two urgent timelines: to recruit COVID-19 survivors within two months of their recovery to ensure that their blood plasma contains a robust enough concentration of antibodies to have a positive effect, and to address the substantial seasonal increase in COVID-19 cases anticipated this fall in the Northern Hemisphere by the Centers for Disease Control and Prevention (CDC) and other public health experts.

“As an early survivor of COVID-19, I was desperate to do whatever was in my power to be a part of the solution. I started Survivor Corps to mobilize and connect the thousands of people affected by COVID-19 to support all ongoing scientific, medical and academic research, and this coalition is furthering our goal,” said Diana Berrent, founder of Survivor Corps. “Inside COVID-19 survivors is the antibody-rich blood plasma that may help stem the tide of this pandemic. The time is now for superhero volunteers to donate their blood plasma and help stop COVID-19 in its tracks.”

Individuals who have recovered from COVID-19, or know someone who has, can visit TheFightIsInUs.org to understand if they may be eligible to donate and find a nearby blood or plasma donor center using a simple self-screening tool. Donating blood plasma is a generally safe and proven process. The coalition offers more than 1,500 locations at which COVID-19 survivors can choose to donate. Donations can be made at both blood and plasma donor centers.

The coalition partners are working on two distinct approaches for treating COVID-19 that both urgently require collection of convalescent plasma now. One approach is the direct transfusion of blood plasma though the Expanded Access Program for convalescent plasma, which is currently being administered with authorization from the Food & Drug Administration by Mayo Clinic. Its safety and efficacy are currently being evaluated through multiple clinical trials in different populations. Blood donor centers throughout the country are currently collecting convalescent plasma from COVID-19 survivors for this purpose. The other approach is the development of a medicine known as a hyperimmune globulin (H-Ig), which is being manufactured now and will be studied in clinical trials this summer. Through the manufacturing process, the plasma is pooled, concentrated and purified, resulting in a vial of medicine with consistent levels of antibodies that is easy to store, distribute and administer to patients. Coalition members developing an H-Ig include CoVIg-19 Plasma Alliance (CSL Behring, Takeda, ADMA Biologics, Biopharma Plasma, Biotest, BPL, GC Pharma, Octapharma and Sanquin) and Grifols.

About The Fight Is In Us

The Fight Is In Us will help advance global research and understanding of COVID-19; progress toward effective, sustainable and widely available convalescent plasma-based therapies; and the medically sound allocation and use of convalescent plasma. The organizations and coalitions involved include leading academic medical institutions (the National COVID-19 Convalescent Plasma Expanded Access Program led by Mayo Clinic, Michigan State University and Washington University School of Medicine in St. Louis); leading plasma companies (Grifols and the CoVIg-19 Plasma Alliance, which includes founding members CSL Behring, Takeda, ADMA Biologics, Biopharma Plasma, Biotest, BPL, GC Pharma, Octapharma and Sanquin); leading blood centers (including the AABB, America’s Blood Centers, Blood Centers of America, New York Blood Centers and Vitalant); healthcare organizations (Anthem and Ashfield Healthcare); COVID-19 survivor groups including Survivor Corps; and media including Ad Council.

The Fight Is In Us is also supported by advisory and technology members. The Bill & Melinda Gates Foundation and the Lasker Foundation are providing advisory support. Microsoft Corp. is providing technology support for the development of TheFightIsInUs.org and a simple self-screening tool for potential donors. MITRE, a not-for-profit organization that operates federally funded research and development centers, is hosting both the website and tool. Uber Health has contributed 25,000 free, roundtrip Uber rides to and from plasma donor centers for those potentially eligible to donate.

The combined efforts of these organizations will contribute specialist advisory expertise, technical guidance and additional support to potentially save more lives — together. But the coalition’s success depends on the urgent support of survivor donors around the world. Those who have recovered from COVID-19 can learn more about how to donate their strength and about the coalition partners at TheFightIsInUs.org.

For Media Inquiries:

Microsoft Media Relations
WE Communications for Microsoft
(425) 638-7777
[email protected]

About AABB

AABB is an international, not-for-profit association representing individuals and institutions involved in the fields of transfusion medicine and biotherapies. The Association is committed to improving health through the development and delivery of standards, accreditation and educational programs that focus on optimizing patient and donor care and safety. AABB membership includes physicians, nurses, scientists, researchers, administrators, medical technologists and other health care providers. AABB members are located in more than 80 countries and AABB accredits institutions in more than 50 countries. For more information, visit: www.aabb.org.

About Bio Products Laboratory (BPL)
Recognising the power of plasma and with over 60 years heritage in the industry, BPL supplies high-quality plasma derived medicines to meet the needs of clinicians, patients and customers globally.  Headquartered in the United Kingdom and with plasma collection centres across the United States, we are dedicated to producing medicines for the treatment of immune deficiencies, bleeding disorders and infectious diseases as well for critical care.  BPL invests in the latest R&D, technology and manufacturing methods, and continuously adapts to ensure that we continue to serve all our stakeholders effectively.  For more information visit http://www.bplgroup.com.

About the CoVIg-19 Plasma Alliance

In an effort to help fight against the COVID-19 pandemic, a new alliance was created in April 2020 to help develop a potential plasma-derived therapy for people at risk for serious complications from COVID-19.

The CoVIg-19 Plasma Alliance brings together world-leading plasma companies to work on the development of an investigational unbranded polyclonal anti-SARS-CoV-2 hyperimmune globulin medicine with the potential to treat patients who are at risk for serious complications from COVID-19.

The “I” and “g” in CoVIg-19 stand for immune globulin, which the CoVIg-19 Plasma Alliance will use to concentrate the antibodies into a potential medicine.

The Alliance, formed by CSL Behring and Takeda, also includes the leading-edge expertise of Biotest, BPL, LFB, and Octapharma. The Bill & Melinda Gates Foundation is providing advisory support. Microsoft is providing technology including the Alliance website and the Plasma Bot for donor recruitment. Experts from the Alliance are collaborating across key aspects such as plasma collection, clinical trial development, and product manufacturing.

About CSL Behring
CSL Behring is a global biotherapeutics leader driven by its promise to save lives. Focused on serving patients’ needs by using the latest technologies, we develop and deliver innovative therapies that are used to treat coagulation disorders, primary immune deficiencies, hereditary angioedema, inherited respiratory disease, and neurological disorders. The company’s products are also used in cardiac surgery, burn treatment and to prevent hemolytic disease of the newborn. CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. The parent company, CSL Limited (ASX:CSL;USOTC:CSLLY), headquartered in Melbourne, Australia, employs more than 26,000 people, and delivers its life-saving therapies to people in more than 70 countries. For more information, visit www.cslbehring.com and for inspiring stories about the promise of biotechnology, visit Vita www.cslbehring.com/Vita.

About Grifols

Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people around the world. Its four divisions – Bioscience, Diagnostic, Hospital and Bio Supplies – develop, produce and market innovative solutions and services that are sold in more than 100 countries.

Pioneers in the plasma industry, Grifols operates a growing network of donation centers worldwide. It transforms collected plasma into essential medicines to treat chronic, rare and, at times, life-threatening conditions. As a recognized leader in transfusion medicine, Grifols also offers a comprehensive portfolio of solutions designed to enhance safety from donation to transfusion. In addition, the company supplies tools, information and services that enable hospitals, pharmacies and healthcare professionals to efficiently deliver expert medical care.

Grifols, with more than 24,000 employees in 30 countries and regions, is committed to a sustainable business model that sets the standard for continuous innovation, quality, safety and ethical leadership.

The company’s class A shares are listed on the Spanish Stock Exchange, where they are part of the Ibex-35 (MCE:GRF). Grifols non-voting class B shares are listed on the Mercado Continuo (MCE:GRF.P) and on the U.S. NASDAQ through ADRs (NASDAQ:GRFS).

For more information, please visit www.grifols.com.

About Mayo Clinic
Mayo Clinic is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the Mayo Clinic News Network for additional Mayo Clinic news and An Inside Look at Mayo Clinic for more information about Mayo.

About Octapharma
Headquartered in Lachen, Switzerland, Octapharma is one of the largest human protein manufacturers in the world, developing and producing human proteins from human plasma and human cell lines. Octapharma employs more than 10,000 people worldwide to support the treatment of patients in 118 countries with products across three therapeutic areas: Hematology; Immunotherapy and Critical care. Octapharma has seven R&D sites and six state-of-the-art manufacturing facilities in Austria, France, Germany, Mexico and Sweden, with a combined capacity of approximately 8 mil litres of plasma per annum. In addition, Octapharma operates more than 140 plasma donation centres across Europe and the US. For more information, visit www.octapharma.com.

About Survivor Corps

Survivor Corps is the largest grassroots movement in America dedicated to actively ending this pandemic. We are mobilizing all those affected by COVID-19 to support all ongoing scientific, medical and academic research to find a vaccine and a cure. We hope to get people back into their communities and back to work, all while fostering the spirit of unity and solidarity that is urgently needed during this time of crisis.

With every passing day, thousands of people across the country are being infected with COVID-19. The vast majority will survive and most will likely develop antibodies to the virus. The mysteries to this virus will be solved, in part, by individual donations to scientific research.

Survivor Corps is the epicenter of HOPE. For more information, visit www.survivorcorps.com.

About Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Diseases, Neuroscience, and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people’s lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries.

For more information, visit https://www.takeda.com.

About Microsoft

Microsoft (Nasdaq “MSFT” @microsoft) enables digital transformation for the era of an intelligent cloud and an intelligent edge. Its mission is to empower every person and every organization on the planet to achieve more.

# # #

Additional Quote Sheet will also be included in press package

AABB

“AABB is proud to support blood centers throughout the country that are collecting potentially lifesaving plasma from COVID-19 survivors. The blood banking community is an integral part of our health care system, and their heroism has truly been on display during this pandemic. Convalescent plasma can be a game-changing therapy for patients in need, and we are pleased to be part of a coalition that recognizes and supports the vital work blood centers do.” — Debra BenAvram, CEO of the American Association of Blood Banks (AABB)

Ad Council

“We are proud to join this critical campaign to educate and empower COVID-19 survivors to donate plasma to help save the lives of others. During this time of uncertainty, we know that this will be a powerful tool in the fight against COVID-19.” — Lisa Sherman, President and CEO of the Ad Council

America’s Blood Centers

“Community blood centers continue to be at the forefront of the nation’s efforts to collect convalescent plasma from individuals who have recovered from COVID-19. ABC member blood centers remain committed to ensuring the availability of convalescent plasma as a potential treatment for COVID-19 patients and are pleased to have the support of Microsoft and other partner organizations in expanding the collection of convalescent plasma throughout the U.S. Community blood centers will remain mobilized in assisting the nation’s COVID-19 response efforts.”— Kate Fry, Chief Executive Officer, America’s Blood Centers

Anthem

“At Anthem, we recognize the importance of building a convalescent plasma biobank in the fight against COVID-19, and are proud to support the efforts to help COVID-19 survivors, patients and their caregivers. Joining the coalition and The Fight Is In Us campaign expands on our partnership and leadership in collaborative efforts with community and healthcare organizations to lead through care, guide the recovery and help shape public-private solutions for the future of healthcare.” — Steve Friedhoff, Chief Clinical Officer, Anthem

Ashfield Healthcare

“Ashfield Healthcare is extremely proud to be part of this collaborative partnership in the fight against COVID-19. Patients are at the core of the healthcare services that we provide, and we’re passionate about leveraging our industry-leading contact center service to support COVID-19 survivors. We are committed to supporting the survivors who will be participating in this critical campaign to donate their plasma.” — Greg Flynn, Global President, Ashfield Healthcare

Bill & Melinda Gates Foundation

“Safe and effective treatments for COVID-19 are urgently needed, and convalescent plasma and hyperimmune globulin could play a key role in saving lives and protecting frontline responders from infection until vaccines are widely available. We’re excited that major academic research institutions and life science companies have joined forces to accelerate the development of potentially lifesaving products, and we’re incredibly grateful to COVID-19 survivors for their essential commitment to this fight.” — Trevor Mundel, President of Global Health, Bill & Melinda Gates Foundation

 CoVIg-19 Plasma Alliance 

“Partnership and collaboration are critical to the success of all the coalition development programs that rely on convalescent plasma donation. The more plasma we can collect, and the earlier we can collect it, will directly impact the speed and scale of our efforts. The growing and active involvement of leading public and private companies from outside the plasma industry, who support the drive for plasma donation, underscores the potential of convalescent plasma to fight this public health crisis. Together, we all share the same goal — to save lives by using the power of this scarce resource in different ways.” — Julie Kim, President of Plasma-Derived Therapies Business Unit, Takeda, and Co-Leader, CoVIg-19 Plasma Alliance

“During times of uncertainty, leaders must lead. The hyperimmune globulin therapy has the potential to be one of the earliest treatment options for COVID-19 and also can be scaled and distributed. We look forward to working with NIAID and health authorities to bring this therapy to patients as early as possible. One of the stated goals of the alliance is to be an effective partner for important institutions such as NIAID and also to help develop coherent regulatory strategies that can give global health authorities the confidence to streamline the approval process of hyperimmune globulin therapy for COVID-19.” — Bill Mezzanotte, Executive Vice President, Head of R&D, CSL Behring, and Co-Leader, CoVIg-19 Plasma Alliance

Grifols

“The development of a hyperimmune globulin for treatment as well as pre- and post-exposure prophylaxis is not just a rapid response to the COVID-19 pandemic. In addition to its attributes as a readily available therapy, it can bridge the time necessary to develop a vaccine. The technology also forms the basis for rapid deployment of a therapy in response to future outbreaks of emerging viruses and other pathogens. The Fight Is In Us provides the opportunity to harness biology’s natural solution to fighting disease.” — David Bell, Chief Innovation Officer, Grifols

Mayo Clinic

“It’s important to know that convalescent plasma is a biological product that has to be obtained from a specific set of patients who have recovered from COVID-19. It cannot be made in a lab. There’s no other source. That’s why reaching as many of these volunteers as possible is so essential.” — Michael Joyner, M.D., Anesthesiologist, Mayo Clinic, and Principal Investigator, Expanded Access Program (EAP) for convalescent plasma to fight COVID-19

“Mayo Clinic’s researchers are working around the clock to accelerate discoveries related to NB SARS-CoV2, the virus, and COVID-19, the disease. Successful outcomes have never been more urgently needed, and we continue to depend on the collaborative efforts of many across the nation and the globe to rapidly discover, translate and apply scientific advances.” — Gregory Gores, M.D., Kinney Executive Dean for Research, Mayo Clinic

Microsoft

“Microsoft has provided the technology infrastructure for a health bot that guides people through their eligibility as a plasma donor and directs them to the nearest donor center. Basically, we’re asking people who have survived COVID-19 to contribute to helping others do the same.” — Peter Lee, Corporate Vice President, AI and Research, Microsoft    

The MITRE Corporation

“We are privileged to serve as a trusted partner to host the website to spread the critical message on how recovered patients can help others in need. Building an army of donors to rapidly develop effective plasma-based treatments is an exemplar of the whole being greater than the sum of its parts.” — Rich Byrne, Senior Vice President, The MITRE Corporation

Uber Health

“There is a long road ahead in the fight against COVID-19, and we must continue to support those on the front lines and those working towards a potential treatment. We at Uber are committed to helping move what matters, and Uber Health is proud to donate rides to the Plasma Collection Coalition, eliminating transportation as a barrier to plasma donation for those who are eligible, and willing, to participate.” — Dan Trigub, Head of Uber Health

Posted on Leave a comment

COVID-19 has only intensified the broadband gap

We are living in a new world, a world racing online as social distancing forces many of us to work, communicate and connect in new ways. In the United States alone, state and local directives have urged 316 million Americans to stay in and, when possible, work from home. As communities around the world adapt to a world with COVID-19, broadband connectivity and access are more critical to our lives and livelihoods than ever before.

Broadband already powers much of our modern lives, but COVID-19 has acted as an accelerant, a fuel of sorts that has driven many essential activities online. All learning, services, commerce, most workplaces and daily interactions online require a high-speed connection to the internet. Those without access to this online world – more than 18 million Americans with 14 million living in rural areas, according to the Federal Communications Commission – risk falling farther behind. While 18 million is a big number – more than the entire populations of Indiana, Iowa and Tennessee combined – a new study has found that the actual number of people lacking access to broadband in the US is closer to 42 million.

We will eventually come out the other end of the COVID-19 crisis, but the future that emerges will look different from the world we left when this crisis began. The future of commerce, work, medicine, education and services will have changed – and, in some instances, permanently.

A problem intensified by COVID-19

Lack of broadband for rural populations, both in the United States and in the developing world, just can’t be ignored. That’s why, in the last three months, we’ve doubled down on our Microsoft Airband Initiative to expand the number of people reached. As of March 31, we’ve helped provide 1.2 million people with access to broadband in rural, previously unserved areas of the United States. This is almost double our total from December 31, 2019, and up from 24,000 people in the whole of 2018. We’re doing the most recent work by donating hotspots and wireless connectivity equipment, and expanding our digital skills offerings by developing COVID-19-specific digital skills offerings for rural communities.

We’re undertaking this work in tandem with ISPs, state and local governments, non-profits such as the National 4-H Council, and other mission-aligned public- and private-sector entities. Eight out of 12 of our commercial ISP partners have taken the FCC’s Keep Americans Connected Pledge, committing to maintaining connectivity to customers who are economically impacted by the crisis. Even those partners that have not formally signed on to the FCC’s pledge have committed to serving their communities by maintaining connectivity for existing customers and connecting new subscribers. The Airband Team has published a customer-ready Airband US COVID-19 Response Summary outlining our programmatic and policy responses to COVID-19 in the US.

We’re not the only ones trying to make a difference. Companies across the country are stepping up to the plate, including tech companies such as Google and T-Mobile. But it isn’t just tech that’s helping – companies such as Land O’Lakes are also working to close the broadband gap. We need the government to step up and meet us halfway.

Policy principles and new federal funding to accelerate much-needed changes

The most significant way to move the dial for Americans without broadband is by changing policy at the federal, state and local level, not only for more funding but to remove roadblocks so that broadband can reach rural and underserved Americans faster. In short, there’s a critical need for Congress to do three things.

First, Congressional action is needed to address the immediate broadband connectivity needs that are having a heightened impact on individuals and communities during the COVID-19 crisis. Funding is needed in the next stimulus bill so that students and teachers have access to remote learning, people have access to their doctors and other telehealth options, and to help people work from home, file and maintain their unemployment benefits, and apply for jobs online.

Second, there’s an urgent need to provide funding to the FCC so it can implement recently enacted broadband-mapping legislation. As we’ve said before, we can’t solve a problem we don’t understand.

Third, additional action is needed to permanently close the broadband gap. With accurate data on broadband availability, we recommend Congress provides funds based on seven important principles. Namely, these funds should be:

  1. Targeted: Any broadband funding mechanism should be designed to address a known market need; for example, the need to deliver broadband access to unserved rural areas and connect students without broadband access before schools start in the fall.
  1. Technology neutral: Broadband funding should be made available on a technology neutral basis.
  1. Broadband-capable: Networks should be required to meet at least the FCC-defined speed for broadband.
  1. Least costly: To minimize costs, funding amounts should be determined through a competitive bidding process (the FCC’s use of reverse auctions is an example of such a mechanism).
  1. Non-distortionary: Any program should aim to minimize market distortions in how funds are collected and how they are distributed.
  1. Deployed quickly: Preference should be given to broadband providers that commit to rapid deployment of broadband networks and services.
  1. Avoid administrative burdens: Programs should minimize red tape and only impose requirements on recipients that are necessary to ensure the integrity of the programs.

With this approach, the country can finally provide the funding needed for ISPs to close the broadband gap. In addition, we support efforts by the FCC, USDA and other federal and state agencies to release funds under new and existing programs to address the needs of vulnerable healthcare workers and patients, educators and learners, and remote workers. This is especially important because, in times of economic downturn, states are more cash-strapped than usual and don’t have resources necessary to make these critical investments.

The COVID-19 virus has created a national crisis. But it has also created an important opportunity. It’s time to galvanize the nation and recognize the obvious. Broadband has become the electricity of the 21st century. Well before the end of the 20th century, we recognized that no American should live without electricity. As we embark on the third decade of the 21st century, every American deserves the opportunity to access broadband.

Tags: , , ,